image
image
user-login
arrow
LIVITE FORTE PHARMONIX PHARMACEUTICALS PVT. LTD
LIVITE FORTE

LIVITE FORTE
PHARMONIX PHARMACEUTICALS PVT. LTD

LIVITE FORTE is a Trademark filed on Mar 02, 2015 in through IP Office.The Trademark is registered to PHARMONIX PHARMACEUTICALS PVT. LTD and was filed by attorney.

LIVITE FORTE

LIVITE FORTE PHARMONIX PHARMACEUTICALS PVT. LTD Trademark Information

Application ID

2914713

Status

Advertised bef acc

Date of Application

Mar 02, 2015

Classes

5

Proprietor(s)

PHARMONIX PHARMACEUTICALS PVT. LTD

Published

Jul 17, 2017

Used Since

10/12/2014

FAQs

The application for LIVITE FORTE was made on Mar 02, 2015
The trademark applicant for LIVITE FORTE is PHARMONIX PHARMACEUTICALS PVT. LTD.
Trademark application has been filed under the class(es) 5.
As per IP India, trademark application is on the following stage: Advertised bef acc.
Listed application Id of LIVITE FORTE is 2914713.
LIVITE FORTE Trademark is a undefined mark.
Disclaimer: Vakilsearch assumes no responsibility or liability for any errors or omissions in the content of this page. The data is derived from mca.gov.in and ipindia.gov.in
bulb
Don’t lose your brand like ”
Our experts are here to assist you in finding a similar trademark.
  • No results found
1 Lakh+
TM Registered since 2011
trademark
star
4.5/5
(19k+ reviews)
google

footer-service

By continuing past this page, you agree to our Terms of Service Cookie Policy Privacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.